Literature DB >> 18075776

Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.

Ronald P Stolk1, Judith G M Rosmalen, Dirkje S Postma, Rudolf A de Boer, Gerjan Navis, Joris P J Slaets, Johan Ormel, Bruce H R Wolffenbuttel.   

Abstract

The risk for multifactorial diseases is determined by risk factors that frequently apply across disorders (universal risk factors). To investigate unresolved issues on etiology of and individual's susceptibility to multifactorial diseases, research focus should shift from single determinant-outcome relations to effect modification of universal risk factors. We present a model to investigate universal risk factors of multifactorial diseases, based on a single risk factor, a single outcome measure, and several effect modifiers. Outcome measures can be disease overriding, such as clustering of disease, frailty and quality of life. "Life course epidemiology" can be considered as a specific application of the proposed model, since risk factors and effect modifiers of multifactorial diseases typically have a chronic aspect. Risk factors are categorized into genetic, environmental, or complex factors, the latter resulting from interactions between (multiple) genetic and environmental factors (an example of a complex factor is overweight). The proposed research model of multifactorial diseases assumes that determinant-outcome relations differ between individuals because of modifiers, which can be divided into three categories. First, risk-factor modifiers that determine the effect of the determinant (such as factors that modify gene-expression in case of a genetic determinant). Second, outcome modifiers that determine the expression of the studied outcome (such as medication use). Third, generic modifiers that determine the susceptibility for multifactorial diseases (such as age). A study to assess disease risk during life requires phenotype and outcome measurements in multiple generations with a long-term follow up. Multiple generations will also enable to separate genetic and environmental factors. Traditionally, representative individuals (probands) and their first-degree relatives have been included in this type of research. We put forward that a three-generation design is the optimal approach to investigate multifactorial diseases. This design has statistical advantages (precision, multiple-informants, separation of non-genetic and genetic familial transmission, direct haplotype assessment, quantify genetic effects), enables unique possibilities to study social characteristics (socioeconomic mobility, partner preferences, between-generation similarities), and offers practical benefits (efficiency, lower non-response). LifeLines is a study based on these concepts. It will be carried out in a representative sample of 165,000 participants from the northern provinces of the Netherlands. LifeLines will contribute to the understanding of how universal risk factors are modified to influence the individual susceptibility to multifactorial diseases, not only at one stage of life but cumulatively over time: the lifeline.

Entities:  

Mesh:

Year:  2007        PMID: 18075776     DOI: 10.1007/s10654-007-9204-4

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  36 in total

Review 1.  Life events, stress and depression: a review of recent findings.

Authors:  Christopher Tennant
Journal:  Aust N Z J Psychiatry       Date:  2002-04       Impact factor: 5.744

Review 2.  Medical consequences of obesity.

Authors:  George A Bray
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

Review 3.  Mode of questionnaire administration can have serious effects on data quality.

Authors:  Ann Bowling
Journal:  J Public Health (Oxf)       Date:  2005-05-03       Impact factor: 2.341

4.  A chronic disease score from automated pharmacy data.

Authors:  M Von Korff; E H Wagner; K Saunders
Journal:  J Clin Epidemiol       Date:  1992-02       Impact factor: 6.437

5.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.

Authors:  M van den Akker; F Buntinx; J F Metsemakers; S Roos; J A Knottnerus
Journal:  J Clin Epidemiol       Date:  1998-05       Impact factor: 6.437

Review 6.  Smoking-related diseases: the importance of COPD.

Authors:  C Zaher; R Halbert; R Dubois; D George; D Nonikov
Journal:  Int J Tuberc Lung Dis       Date:  2004-12       Impact factor: 2.373

7.  Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care.

Authors:  J Ormel; M VonKorff; T B Ustun; S Pini; A Korten; T Oldehinkel
Journal:  JAMA       Date:  1994-12-14       Impact factor: 56.272

8.  Social consequences of psychiatric disorders, I: Educational attainment.

Authors:  R C Kessler; C L Foster; W B Saunders; P E Stang
Journal:  Am J Psychiatry       Date:  1995-07       Impact factor: 18.112

9.  The case for a US prospective cohort study of genes and environment.

Authors:  Francis S Collins
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

Review 10.  Statistical issues in life course epidemiology.

Authors:  Bianca L De Stavola; Dorothea Nitsch; Isabel dos Santos Silva; Valerie McCormack; Rebecca Hardy; Vera Mann; Tim J Cole; Susan Morton; David A Leon
Journal:  Am J Epidemiol       Date:  2005-11-23       Impact factor: 4.897

View more
  115 in total

1.  Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.

Authors:  Andrea Ganna; Marie Reilly; Ulf de Faire; Nancy Pedersen; Patrik Magnusson; Erik Ingelsson
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

2.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

3.  Recent trends in publications in the European Journal of Epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

4.  Medical demography and epidemiology: dizygotic twins.

Authors:  Luc Gustaaf Antoon Bonneux
Journal:  Eur J Epidemiol       Date:  2009-03-17       Impact factor: 8.082

5.  Is the time right for translation research in genomics?

Authors:  A Cecile J W Janssens
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

6.  Genetic determinants of P wave duration and PR segment.

Authors:  Niek Verweij; Irene Mateo Leach; Malou van den Boogaard; Dirk J van Veldhuisen; Vincent M Christoffels; Hans L Hillege; Wiek H van Gilst; Phil Barnett; Rudolf A de Boer; Pim van der Harst
Journal:  Circ Cardiovasc Genet       Date:  2014-05-21

Review 7.  Population biobanks and returning individual research results: mission impossible or new directions?

Authors:  Susan E Wallace; Alastair Kent
Journal:  Hum Genet       Date:  2011-06-05       Impact factor: 4.132

8.  Is rigorous retrospective harmonization possible? Application of the DataSHaPER approach across 53 large studies.

Authors:  Isabel Fortier; Dany Doiron; Julian Little; Vincent Ferretti; François L'Heureux; Ronald P Stolk; Bartha M Knoppers; Thomas J Hudson; Paul R Burton
Journal:  Int J Epidemiol       Date:  2011-07-30       Impact factor: 7.196

9.  Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.

Authors:  Elise I Klaver; Hannah C M van Loon; Riejanne Stienstra; Thera P Links; Joost C Keers; Ido P Kema; Anneke C Muller Kobold; Melanie M van der Klauw; Bruce H R Wolffenbuttel
Journal:  Thyroid       Date:  2013-09       Impact factor: 6.568

10.  Molgenis-impute: imputation pipeline in a box.

Authors:  Alexandros Kanterakis; Patrick Deelen; Freerk van Dijk; Heorhiy Byelas; Martijn Dijkstra; Morris A Swertz
Journal:  BMC Res Notes       Date:  2015-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.